RWE 101 – ISPE GPP
The International Society of Pharmacoepidemiology (ISPE) Good Pharmacoepidemiology Practices (GPP) provides guidance for the conduct and reporting of pharmacoepidemiologic studies. The key points of ISPE GPP include:
Study Design and Conduct: ISPE GPP emphasizes the importance of study design and conduct to ensure the validity and reliability of study results. The guide provides guidance on study design, sample selection, data collection, and analysis.
Data Sources and Quality: ISPE GPP provides guidance on the selection and use of data sources, such as administrative databases, electronic health records, and patient registries. The guide emphasizes the importance of data quality and the need to validate data sources and ensure data completeness.
Ethical Considerations: ISPE GPP emphasizes the importance of ethical considerations in pharmacoepidemiologic studies, including informed consent, confidentiality, and protection of human subjects.
Reporting and Dissemination of Results: ISPE GPP provides guidance on the reporting and dissemination of study results, including the need to provide clear and transparent reporting of study methods, results, and limitations.
Collaboration and Communication: ISPE GPP emphasizes the importance of collaboration and communication among researchers, stakeholders, and the public to ensure the appropriate use and interpretation of study results.
Share this story...
Real World Evidence (RWE) 101 – Data Tokenization
RWE 101 - 4 Potential Uses for Improving Drug Development Real world evidence (RWE) refers to data collected outside the context of traditional clinical trials, such as [...]
Real World Evidence (RWE) 101 – Primary Data versus Secondary Data
RWE 101 - Primary Data versus Secondary Data Primary data and secondary data are two types of data used in research. The main difference between the two [...]
RWE 101 – Secondary Use of Existing Data
RWE 101 - Secondary Use of Existing Data Secondary use of existing data refers to the practice of analyzing data that was collected for a different purpose [...]
RWE 101 – Why is there so much excitement about the use of AI in the context of real world evidence?
RWE 101 - Why is there so much excitement about the use of AI in the context of real world evidence? The use of Artificial Intelligence (AI) [...]
RWE 101 – What is the Difference Between an IRB and a REC?
RWE 101 - What is the Difference Between an IRB and a REC? An Institutional Review Board (IRB) and a Research Ethics Committee (REC) are two different [...]
RWE 101 – Do I Need IRB Approval for My Observational Study?
RWE 101 - Do I Need IRB Approval for My Observational Study? In general, observational studies that involve human subjects require Institutional Review Board (IRB) approval to [...]
